Mostafa Ronaghi has joined BaseHealth's board of directors.
Ronaghi currently serves as Illumina's chief technology officer and senior vice president. Before joining Illumina, he founded several life sciences companies including ParAllele BioScience, which was acquired by Affymetrix, as well as Avantome and NextBio, both of which were acquired by Illumina. He also previously spent nine years as a principal investigator at the Stanford Genome Technology Center.
Genome British Columbia has appointed Joseph Garcia and Jock Finlayson to its board of directors.
Garcia is a law partner at Blake, Cassels and Graydon, where he practices in the securities and commercial areas for clients in the life sciences and technology sectors, and he is a member of the board of directors of LifeSciences BC.
Finlayson is executive VP and chief policy officer at the Business Council of British Columbia, where he directs the council's work on economic, fiscal, tax, environmental, regulatory, and human capital issues.
Pacific Biosciences' shareholders have re-elected Brook Byers, John Milligan, and Lucy Shapiro to the company's board of directors.